Therapy-related acute myeloid leukemia with t(2;11)(q37;q23) after treatment for osteosarcoma

Cancer Genetics and Cytogenetics

Volumn 203, Issue 2, 2010, Pages 288-291

  Bielorai, Bella ^a   Meyer, Claus ^b   Trakhtenbrot, Luba ^a   Golan, Hana ^a   Rozner, Esther ^a   Amariglio, Ninette ^a   Izraeli, Shai ^a   Marschalek, Rolf ^b   Toren, Amos ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD33 ANTIGEN; CD64 ANTIGEN; CISPLATIN; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GEMTUZUMAB OZOGAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; IFOSFAMIDE; METHOTREXATE; MICROSOMAL AMINOPEPTIDASE; MIXED LINEAGE LEUKEMIA PROTEIN; SEPTIN; SEPTIN 2; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; CELL INFILTRATION; CHROMOSOME 11Q; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 2; CYTOGENETICS; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE IDENTIFICATION; GENE REARRANGEMENT; HUMAN; ILEUM; IMMUNOPHENOTYPING; INVERSE POLYMERASE CHAIN REACTION; LEUKOCYTOSIS; MALE; MULTIPLE CYCLE TREATMENT; MYELOBLAST; OSTEOSARCOMA; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ADOLESCENT; AGED; BONE NEOPLASMS; CHILD; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 2; CYTOGENETICS; FEMALE; HUMANS; ILEUM; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 78650004791     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.08.002     Document Type: Article

References (17)

1. Aung L., Gorlick R.G., Shi W., Thaler H., Shorter N.A., Healy J.H., et al. Second malignant neoplasms in long-term survivors of osteosarcoma. Cancer 2002, 95:1728-1734.
2. Kawai A., Sugihara S., Naito N., Ozaki T., Isu K., Hatae Y., et al. Development of acute myeloid leukemia after chemotherapy for osteosarcoma. Clin Orthop Relat Res 2001, 391:239-246.
3. Escudero M.C., Lassaletta A., Sevilla J., Fernandez-Plaza S., Perez A., Diaz M.A., et al. Chemotherapy-related secondary acute myeloid leukemia in patients diagnosed with osteosarcoma. J Pediatr Hematol Oncol 2004, 26:454-456.
4. Larson R.A. Etiology and management of therapy-related myeloid leukemia. Hematology 2007, 453-459.
5. Meyer C., Kowarz E., Hofmann J., Renneville A., Zuna J., Trka J., et al. New insights to the MLL recombinome of acute leukemias. Leukemia 2009, 8:1490-1499.
6. Winick N.J., McKenna R.W., Shuster J.J., Schneider N.R., Borowitz M.J., Bowman W.P., et al. Seconadary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol 1993, 11:209-217.
7. Cerveira N., Correia C., Bizarro S., Pinto C., Lisboa S., Mariz J.M., et al. SEPT2 is a new fusion $$partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23). Oncogene 2006, 25:6147-6152.
8. van Binsbergen E., de Weerdt O., Buijs A. A new subtype of MLL-SEPT2 fusion transcript in therapy-related acute myeloid leukemia with t(2;11)(q37;q23): a case report and literature review. Cancer Genet Cytogenet 2007, 176:72-75.
9. Snijder S., Mellink C.H.M., van der Lelie H. Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia. Cancer Genet Cytogenet 2008, 180:149-152.
10. Shaffer L.G., Tommerup N. An international system for human cytogenetic nomenclature. Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature 2005, Karger, Basel.
11. Cohen N., Novikov I., Hardan I., Esa A., Brok-Simoni F., Amariglio N., et al. Standardization criteria for the detection of BCR/ABL fusion in interphase nuclei of CML patients by FISH technique. Cancer Genet Cytogenet 2000, 123:102-108.
12. Meyer C., Schneider B., Reichel M., Angermueller S., Strehl S., Schnittger S., et al. Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. Proc Natl Acad Sci U S A 2005, 102:449-454.
13. Meyer C., Schneider B., Jakob S., Strehl S., Attarbaschi A., Schnittger S., et al. The MLL recombinome of acute leukemias. Leukemia 2006, 20:777-784.
14. Ma S.K., Wan T.S.K., Au W.Y., Fung L.F., So C.K., Chan L.C. Chromosome 11q deletion in myeloid malignancies. Leukemia 2002, 16:935-955.
15. Russell S.E.H., Hall P.A. Do septins have a role in cancer?. Br J Cancer 2005, 93:499-503.
16. Santos J., Cerveira N., Bizarro S., Riberio F.R., Correia C., Torres L., et al. Expression pattern of the septin gene family in acute myeloid leukemia with and without MLL-SEPT fusion genes. Leuk Res 2010, 34:615-621.
17. Balgobind B.V., Raimondi S.C., Harbott J., Zimmermann M., Alonzo T.A., Auvrignon A., et al. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood 2009, 114:2489-2496.